Clinical Trials in Washington

Showing 6661-6680 of 7,241 trials

AZD7268 Safety and Tolerability Study

NCT01020799

The purpose of this study is to prove the principle that treatment with AZD7268 reduces depressive symptoms in patients with Major Depressive Disorder (MDD) compared with placebo.

Major Depressive Disorder

AstraZeneca247 participantsStarted Nov 2009

Birmingham, Alabama, United States • Garden Grove, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 336 miles

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

NCT00107120

Depression affects approximately 2.5% of children and 8% of adolescents. Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to provide a systematic evaluation of the safety and efficacy of escitalopram in the treatment of depressed pediatric patients, 12 to 17 years of age. Patients completing the study will be eligible to enter an open-label extension study.

Major Depressive Disorder

Forest Laboratories312 participantsStarted Mar 2005

Sacramento, California, United States • San Diego, California, United States • San Diego, California, United States +25 more locations

AZD7268 Safety and Tolerability Study

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

Find Trials by Condition in Washington

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia

EPO906 Therapy in Patients With Advanced Kidney Cancer

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Use of Cold and Compression Therapy With Total Knee Replacement Patients

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

ETEC Logistics Trial (TREK)

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy

Testing the Developmental Origins Hypothesis

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Pain Associated With Endometriosis

Vaginal Infection Study

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder